使用本網站需要啟用 JavaScript, 請啟用后刷新頁面獲得更好的體驗
亚洲精品午夜精品,日本二手网站,国产AⅤ爽AV久久久久成人社区,日本一二三区不收费av
<b id="tiqrp"></b>
<bdo id="tiqrp"></bdo>
登錄
注冊
首頁
個人居家檢測
臨床應用研究
科研合作項目
合作與服務
社區
純合片段分析
姓氏祖源
祖源平均臉
基因關系
基因保險助手
原始數據
使用 WeGene 需要啟用 Cookies, 請啟用后刷新頁面獲得更好的體驗
社區首頁
小組
代謝效率
代謝效率
發起討論
代謝效率
1 個討論
只看精華帖
按熱門排序
按最新排序
代謝效率什么意思？
直爽的ESRRG基因
? 2016-08-04 11:17
3339
0
? 來自相關小組
發起討論
代謝效率
1 個討論
相關基因
HIF1A
位點：RS11549465
AMPD1
位點：RS17602729
PPARD
位點：RS2016520
位點：RS2267668
PPARGC1A
位點：RS8192678
Nagy G, et al. Association of hypoxia inducible factor-1 alpha gene polymorphism with both type 1 and type 2 diabetes in a Caucasian (Hungarian) sample. 2009
Torres O, et al. Lack of association between hypoxia inducible factor-1 alpha gene polymorphisms and biopsy-proven giant cell arteritis. 2010
Knechtel G, et al. Single nucleotide polymorphisms in the hypoxia-inducible factor-1 gene and colorectal cancer risk. 2010
Ruiz-Tovar J, et al. Association of thymidylate synthase and hypoxia inducible factor-1alpha DNA polymorphisms with pancreatic cancer. 2012
Hlatky MA, et al. Polymorphisms in hypoxia inducible factor 1 and the initial clinical presentation of coronary disease. 2007
Heino S, et al. Non-synonymous sequence variants within the oxygen-dependent degradation domain of the HIF1A gene are not associated with pre-eclampsia in the Finnish population. 2008
Droma Y, et al. Two hypoxia sensor genes and their association with symptoms of acute mountain sickness in Sherpas. 2008
Wipff J, et al. Association of hypoxia-inducible factor 1A (HIF1A) gene polymorphisms with systemic sclerosis in a French European Caucasian population. 2015
Konac E, et al. Genetic variations in the hypoxia-inducible factor-1alpha gene and lung cancer. 2009
Zheng ZL, et al. Genetic polymorphisms of hypoxia-inducible factor-1 alpha and cardiovascular disease in hemodialysis patients. 2009
Eynon N, et al. Is the interaction between HIF1A P582S and ACTN3 R577X determinant for power/sprint performance? 2010
Emanuele E, et al. A multilocus candidate approach identifies ACE and HIF1A as susceptibility genes for cellulite. 2010
D?ring F, et al. A common haplotype and the Pro582Ser polymorphism of the hypoxia-inducible factor-1alpha (HIF1A) gene in elite endurance athletes. 2010
Xu CF, et al. Pazopanib-induced hyperbilirubinemia is associated with Gilbert's syndrome UGT1A1 polymorphism. 2010
Kim SJ, et al. The association of 18F-deoxyglucose (FDG) uptake of PET with polymorphisms in the glucose transporter gene (SLC2A1) and hypoxia-related genes (HIF1A, VEGFA, APEX1) in non-small cell lung cancer. SLC2A1 polymorphisms and FDG-PET in NSCLC patients. 2010
Qin C, et al. The polymorphisms in the VHL and HIF1A genes are associated with the prognosis but not the development of renal cell carcinoma. 2012
Gerger A, et al. Pharmacogenetic angiogenesis profiling for first-line Bevacizumab plus oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. 2011
Li P, et al. Genetic polymorphisms in HIF1A are associated with prostate cancer risk in a Chinese population. 2012
Bravatà V, et al. Genotyping analysis and 1?FDG uptake in breast cancer patients: a preliminary research. 2013
Fu SL, et al. A polymorphism in the 3' untranslated region of Hypoxia-Inducible Factor-1 alpha confers an increased risk of cervical cancer in a?Chinese population. 2013
Fraga A, et al. The HIF1A functional genetic polymorphism at locus +1772 associates with progression to metastatic prostate cancer and refractoriness to hormonal castration. 2014
Fu SL, et al. A polymorphism in the 3' untranslated region of Hypoxia-Inducible Factor-1 alpha confers an increased risk of cervical cancer in a Chinese population. 2015
Feng CC, et al. Lack of association between the polymorphisms of hypoxia-inducible factor 1A (HIF1A) gene and SLE susceptibility in a Chinese population. 2014
Liu J, et al. 1790 G/A polymorphism, but not 1772 C/T polymorphism, is significantly associated with cancers: an update study. 1772
Genetta T, et al. A novel bipartite intronic splicing enhancer promotes the inclusion of a mini-exon in the AMP deaminase 1 gene. 2001
Lucia A, et al. C34T mutation of the AMPD1 gene in an elite white runner. 2006
Anderson JL, et al. A common variant of the AMPD1 gene predicts improved cardiovascular survival in patients with coronary artery disease. 2000
Ramakers BP, et al. Circulating adenosine increases during human experimental endotoxemia but blockade of its receptor does not influence the immune response and subsequent organ injury. 2011
Yamaguchi-Kabata Y, et al. Distribution and effects of nonsense polymorphisms in human genes. 2008
Won HH, et al. Cataloging coding sequence variations in human genome databases. 2008
Ruiz JR, et al. Is there an optimum endurance polygenic profile? 2009
Eynon N, et al. Genes for elite power and sprint performance: ACTN3 leads the way. 2013
Hennis PJ, et al. Genetic factors associated with exercise performance in atmospheric hypoxia. 2015
Gallicchio L, et al. Genetic polymorphisms of peroxisome proliferator-activated receptors and the risk of cardiovascular morbidity and mortality in a community-based cohort in washington county, Maryland. 1989
Burch LR, et al. A single nucleotide polymorphism on exon-4 of the gene encoding PPARdelta is associated with reduced height in adults and children. 2009
Ahmetov II, et al. The combined impact of metabolic gene polymorphisms on elite endurance athlete status and related phenotypes. 2009
Wei XL, et al. The peroxisome proliferator-activated receptor delta +294T > C polymorphism and alcohol consumption on serum lipid levels. 2011
Holzapfel J, et al. PPARD haplotype influences cholesterol metabolism but is no risk factor of Alzheimer's disease. 2006
Chang SC, et al. Polymorphism of genes related to insulin sensitivity and the risk of biliary tract cancer and biliary stone: a population-based case-control study in Shanghai, China. 2008
Sáez ME, et al. Interaction between Calpain 5, Peroxisome proliferator-activated receptor-gamma and Peroxisome proliferator-activated receptor-delta genes: a polygenic approach to obesity. 2008
Hsing AW, et al. Variants in inflammation genes and the risk of biliary tract cancers and stones: a population-based study in China. 2008
Eynon N, et al. Is there an interaction between PPARD T294C and PPARGC1A Gly482Ser polymorphisms and human endurance performance? 2009
Burch LR, et al. Peroxisome proliferator-activated receptor-delta genotype influences metabolic phenotype and may influence lipid response to statin therapy in humans: a genetics of diabetes audit and research Tayside study. 2010
Halvorsen M, et al. Disease-associated mutations that alter the RNA structural ensemble. 2010
Hildebrandt MA, et al. Genetic variants in inflammation-related genes are associated with radiation-induced toxicity following treatment for non-small cell lung cancer. 2010
Bouchard-Mercier A, et al. Effects of peroxisome proliferator-activated receptors, dietary fat intakes and gene-diet interactions on peak particle diameters of low-density lipoproteins. 2011
Luo WS, et al. [Association of both peroxisome proliferator-activated receptor, gene-gene interactions and the body mass index]. 2012
Luo W, et al. Association of peroxisome proliferator-activated receptor α/δ/γ with obesity, and gene-gene interaction, in the Chinese Han population. 2013
Ye H, et al. Genetic associations with coronary heart disease: meta-analyses of 12 candidate genetic variants. 2013
Yu H, et al. [Effects related to gene-gene interactions of peroxisome proliferator-activated receptor on essential hypertension]. 2013
Gu SJ, et al. [Gene-gene interactions among the peroxisome proliferator-activated receptor polymorphisms for hypertriglyceridemia]. 2012
Yin RX, et al. Interactions of several single nucleotide polymorphisms and high body mass index on serum lipid traits. 2013
Thamer C, et al. Variations in PPARD determine the change in body composition during lifestyle intervention: a whole-body magnetic resonance study. 2008
San-Millán JL, et al. The role of genetic variation in peroxisome proliferator-activated receptors in the polycystic ovary syndrome (PCOS): an original case-control study followed by systematic review and meta-analysis of existing evidence. 2010
Stefan N, et al. Genetic variations in PPARD and PPARGC1A determine mitochondrial function and change in aerobic physical fitness and insulin sensitivity during lifestyle intervention. 2007
Ordelheide AM, et al. The myocyte expression of adiponectin receptors and PPARδ is highly coordinated and reflects lipid metabolism of the human donors. 2011
Santiago C, et al. Mitochondriogenesis genes and extreme longevity. 2013
Vimaleswaran KS, et al. The Gly482Ser genotype at the PPARGC1A gene and elevated blood pressure: a meta-analysis involving 13,949 individuals. 2008
Kacerovsky-Bielesz G, et al. Short-term exercise training does not stimulate skeletal muscle ATP synthesis in relatives of humans with type 2 diabetes. 2009
Habalová V, et al. Rapid and cost effective genotyping method for polymorphisms in PPARG, PPARGC1 and TCF7L2 genes. 2009
Brito EC, et al. PPARGC1A sequence variation and cardiovascular risk-factor levels: a study of the main genetic effects and gene x environment interactions in children from the European Youth Heart Study. 2009
Zhu S, et al. Evaluation of the association between the PPARGC1A genetic polymorphisms and type 2 diabetes in Han Chinese population. 2009
Povel CM, et al. Glucose levels and genetic variants across transcriptional pathways: interaction effects with BMI. 2010
Clark J, et al. Association of PGC-1alpha polymorphisms with age of onset and risk of Parkinson's disease. 2011
Nitz I, et al. Analysis of PGC-1alpha variants Gly482Ser and Thr612Met concerning their PPARgamma2-coactivation function. 2007
Franks PW, et al. PPARGC1A coding variation may initiate impaired NEFA clearance during glucose challenge. 2007
Huang HY, et al. Frequencies of single nucleotide polymorphisms in genes regulating inflammatory responses in a community-based population. 2007
Ahituv N, et al. Medical sequencing at the extremes of human body mass. 2007
Wang S, et al. Polymorphisms of the peroxisome proliferator-activated receptor-gamma coactivator-1alpha gene are associated with hypertrophic cardiomyopathy and not with hypertension hypertrophy. 2486
Lai CQ, et al. PPARGC1A variation associated with DNA damage, diabetes, and cardiovascular diseases: the Boston Puerto Rican Health Study. 2008
Su Y, et al. [Association study between PPARGC1A Thr394Thr/ Gly482Ser polymorphisms and type 2 diabetes]. 2008
Feng Y, et al. Ser1369Ala variant in sulfonylurea receptor gene ABCC8 is associated with antidiabetic efficacy of gliclazide in Chinese type 2 diabetic patients. 2008
Simoni M, et al. Functional genetic polymorphisms and female reproductive disorders: Part I: Polycystic ovary syndrome and ovarian response. 2008
Maver A, et al. Peroxisome proliferator-activated receptor gamma/Pro12Ala polymorphism and peroxisome proliferator-activated receptor gamma coactivator-1 alpha/Gly482Ser polymorphism in patients with sarcoidosis. 2008
Weydt P, et al. The gene coding for PGC-1alpha modifies age at onset in Huntington's Disease. 2009
Taherzadeh-Fard E, et al. PGC-1alpha as modifier of onset age in Huntington disease. 2009
Ruiz JR, et al. Is there an optimum endurance polygenic profile? 2009
Deeb SS, et al. The role of the PGC1α Gly482Ser polymorphism in weight gain due to intensive diabetes therapy. 2009
Eynon N, et al. Do PPARGC1A and PPARalpha polymorphisms influence sprint or endurance phenotypes? 2010
Eynon N, et al. Is there an interaction between PPARD T294C and PPARGC1A Gly482Ser polymorphisms and human endurance performance? 2009
Che HV, et al. Localization of sequence variations in PGC-1α influence their modifying effect in Huntington disease. 2011
Jing C, et al. Meta-analysis of association studies between five candidate genes and type 2 diabetes in Chinese Han population. 2012
Lin YC, et al. A common variant in the peroxisome proliferator-activated receptor-γ coactivator-1α gene is associated with nonalcoholic fatty liver disease in obese children. 2013
Inamine T, et al. Association of genes involved in bile acid synthesis with the progression of primary biliary cirrhosis in Japanese patients. 2013
Ha CD, et al. Relationship of PGC-1α gene polymorphism with insulin resistance syndrome in Korean children. 2015
Shibata N, et al. Lack of Genetic Associations of PPAR-γ and PGC-1α with Alzheimer's Disease and Parkinson's Disease with Dementia. 2013
Franks PW, et al. Common variation at PPARGC1A/B and change in body composition and metabolic traits following preventive interventions: the Diabetes Prevention Program. 2014
Barth SW, et al. Moderate effects of apple juice consumption on obesity-related markers in obese men: impact of diet-gene interaction on body fat content. 2012
Santiago C, et al. Mitochondriogenesis genes and extreme longevity. 2013
查看參考文獻
首頁
個人基因檢測
臨床應用研究
科研合作項目
合作與服務
示例報告
下載 APP
社區
關于 WeGene
關于我們
媒體新聞
倫理委員會
隱私協議
加入我們
服務協議
價格保護
幫助中心
關于基因檢測
賬戶購買
樣本寄送
報告解讀
隱私安全
關于第三方數據
社區分享
開放平臺
申請成為開發者
開發文檔
客服微信公眾號
聯系我們
客服郵箱：
[email protected]
合作咨詢：
[email protected]
© 2025 WeGene. All Rights Reserved
深圳市市場監督管理局企業主體身份公示
|
粵ICP備15012185號
| 互聯網藥品信息服務資格證書:（粵）-非經營性-2023-0379
中文
English
<track id="ffr4e"></track>
<dfn id="ffr4e"></dfn>
主站蜘蛛池模板：
隆安县
|
北安市
|
鄂尔多斯市
|
安吉县
|
曲水县
|
潮州市
|
睢宁县
|
乐安县
|
江达县
|
治县。
|
化州市
|
延寿县
|
达尔
|
英超
|
阿荣旗
|
尼玛县
|
武定县
|
晋江市
|
什邡市
|
新和县
|
开原市
|
兴化市
|
无为县
|
安吉县
|
清原
|
延津县
|
邓州市
|
会宁县
|
正蓝旗
|
垣曲县
|
酒泉市
|
中方县
|
乌兰察布市
|
东乡族自治县
|
大丰市
|
壤塘县
|
桐庐县
|
闽清县
|
黄冈市
|
井冈山市
|
清镇市
|
<menuitem id="elzqm"><b id="elzqm"></b></menuitem>
<bdo id="elzqm"><dl id="elzqm"><dd id="elzqm"></dd></dl></bdo>
<bdo id="elzqm"><rt id="elzqm"></rt></bdo>
<ul id="elzqm"><em id="elzqm"><small id="elzqm"></small></em></ul>
純合片段分析
姓氏祖源
祖源平均臉
基因關系
基因保險助手
原始數據
深圳市市場監督管理局企業主體身份公示
中文
English